LSI USA '23 filling fast. Register Now

Afferent Pharmaceuticals

First-in-class, small molecule compounds that successfully manage and treat chronic pain, by inhibiting P2X3 receptors

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Afferent Pharmaceuticals plus 5456 other startups.

Start Free 7 Day Trial Now

Learn More About Afferent Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Our Clients